baber/WOPTO huggingface dataset:
Patent NZ-502949-A (NZ)
Title: Petri dish with keyway notches to enable lid and base to be spaced to either allow or restrict gas flow
Inventor: MURPHY PAUL A
IPC: C12M1/22
Filed: 2000-02-18
Abstract: Provided are container, more particularly petri dishes, having a lid that can be oriented and placed on a dish in a number of predetermined positions to either restrict or permit gas exchange between the interior and exterior of the container.  The container comprises a base portion (Fig 1) having a bottom surface (16) and a peripheral wall (18) around the surface, a lid portion (Fig 2) having a top plate (20) and peripheral wall (22) around the top plate, the lid wall having a complementary shape with respect to the base wall to retain the lid portion on the base portion in a plurality of predetermined positions; and a selector (24, 26) for orienting and placing the lid portion on the base portion in one of the positions to either restrict or permit gas flow between the base portion and the lid portion.
Patent NZ-503488-A (NZ)
Title: Polysaccharide conjugate derivatives capable of binding to the cell surface of antigen processing cells (APCs) and acting as immunoadjuvants
Inventor: MARCIANI DANTE J
IPC: C08B37/08
Filed: 1998-10-02
Abstract: Polysaccharide conjugates that comprise: a polysaccharide that binds to surface-receptors present on Antigen Presenting Cells (APCs), conjugated to one or more compounds having stable carbonyl groups covalently attached, either directly or via a bifunctional linker. The conjugates are useful as immuno-stimulants and adjuvants.
Patent NZ-503714-A (NZ)
Title: A coding method and apparatus for the storage and use of anaesthetic drugs
Inventor: MERRY ALAN FORBES
IPC: A61M5/00
Filed: 1998-09-03
Abstract: A method and apparatus involving the coding, via colours or other identification means, of substances to be used in administration procedures, including providing a support means (10) having areas (11) correspondingly coded (12) so as to provide an additional reference or confirmation means for users of the invention and reducing the inherent risks associated with administration procedures prone to error. The method includes the steps of positioning coded articles in a first position (2a), prior to use, and placing said articles in a second coded position (2b) after use, including the steps of monitoring and recording the use steps in simultaneous actual time, use confirmation monitoring and subsequent use verification or recordal. Also described is the step of comparing the procedural administration steps or use of the coded articles against predetermined patterns including audible or other sensory confirmation of predetermined usage or range of usage, and warning against non-predetermined and thus potentially dangerous use.
Patent NZ-503979-A (NZ)
Title: Ladle nozzle for continuous casting having an upstream portion divergent towards a constant cross-section downstream portion
Inventor: BOISDEQUIN VINCENT
IPC: B22D41/50
Filed: 1998-10-14
Abstract: A ladle nozzle for continuous casting which allows for a reduction in the speed of injection of liquid steel between the ladle and the distributor while at the same time preserving a given flow rate.  The ladle nozzle has a collar portion (1), for the connection to the casting ladle, and a tubular conduit (2).  The tubular conduit (2) is made up of a first downstream portion (3) of substantially constant cross-section at the distributor end, and a second upstream portion (4) which is divergent towards the downstream region.  The portions (3) and (4) are connected together in a plane where their cross sections are identical, at least on the inside.  Both the portions (3) and (4) have a divergence which is substantially constant and, therefore, have the shape of truncated cones.
Patent NZ-505500-A (NZ)
Title: Cell surface glycoproteins associated with human b cell lymphomas - ulbp, dna and polypeptides
Inventor: COSMAN DAVID JOHN
IPC: C12N15/12
Filed: 1998-12-17
Abstract: Purified and isolated ULBP polypeptides, the nucleic acids encoding such polypeptides, processes for production of recombinant forms of such polypeptides, antibodies generated against these polypeptides, fragmented peptides derived from these polypeptides, and the uses of the above. ULBP polypeptide can be found on the surface of human B cell lymphomas. Mammalian forms of ULBP polypeptide in isolated or purified forms are provided. In addition, isolated nucleic acids encoding ULBP polypeptides and expression vectors comprising a cDNA encoding ULBP poypeptides are provided. The ULBP polypeptides can be isolated or synthesized and used to prepare antibodies, and in particular monoclonal antibodies, against the polypeptides. The antibodies, in turn, are useful for detecting the presence of ULBP polypeptides in human cell samples, which can be correlated with the existence of a malignant condition in a patient. ULBP polypeptides stimulate IFN- gamma production, NK cell proliferation, and CTL activity.
Patent NZ-506028-A (NZ)
Title: Ergonomic seat with inclined femoral portion
Inventor: HERBERT JEFFREY
IPC: A47C7/00
Filed: 1999-01-29
Abstract: A seat includes a seat portion connected to a base so that it can be supported on the ground. In addition to a front, a rear and two sides, the seat portion has an upwardly inclined portion, an inclined support portion, and a substantially flat horizontal portion. The upwardly inclined portion inclines upwardly from the front of the seat portion to a first intermediate position between the front and rear of the seat portion. The inclined support portion extends between a second intermediate position and the rear of the seat portion. The horizontal portion extends from the first intermediate position to the second intermediate position. The upwardly inclined portion supports the femurs and knees in a position below a person's acetabulum. The horizontal portion receives and holds the ischial bones when the person sits down, and the inclined support portion supports the gluteal muscles and sacra iliac ligaments
Patent NZ-507623-A (NZ)
Title: Positive modulator of a nicotinic acetylcholine receptor
Inventor: GURLEY DAVID
IPC: A61K31/40
Filed: 1999-04-28
Abstract: A pharmaceutical composition comprising a positive modulator of a nicotinic receptor agonist, wherein the said positive modulator is 5-hydroxyindole, together with a pharmaceutically acceptable carrier, said positive modulator having the capability to increase the efficacy of the said nicotinic receptor agonist. Also described is the use in the manufacture of a medicament for the treatment of Alzheimer's disease, attention deficit hyperactivity disorder, schizophrenia, anxiety or nicotine addiction.
Patent NZ-508597-A (NZ)
Title: Halichondrin analogs useful as anticancer and antimitotic agents
Inventor: LITTLEFIELD BRUCE A
IPC: A61P35/00
Filed: 1999-06-16
Abstract: A macrocyclic compound or a pharmaceutically acceptable salt thereof has the formula wherein: A is a optionally saturated optionally substituted hydrocarbon skeleton; each of D and D' is independently R3 and OR3; R3 is H, alkyl, or haloalkyl; n is 0 or 1; E is R5 or OR5 ; G is O, S, CH2, or NR6; Each of J, J', Y, Y', Z, Z', U and U' are independently H, alkoxy, or alkyl or J and J' and/or U and U' and/or Y and Y' and/or Z and Z' taken together are =CH or -O-alkylene-O-; Q is alkyl; T is optionally substituted ethylene or ethenylene; X is H or alkoxy and Each of R5, and R6 is independently H, alkyl, haloalkyl, hydroxyalkyl, aminoalkyl, aryl, haloaryl, hydroxyaryl, alkoxyaryl, arylalkyl, alkylaryl, haloarylalkyl, alkylhaloaryl, alkoxyarylalkyl, heterocyclic radical, heterocyclic alkyl, heteroaryl or heteroarylalkyl. The compounds have anticancer or antimitotic (mitosis-blocking) activity.
Patent NZ-512194-A (NZ)
Title: A pharmaceutical composition comprising cyclosporin in a lipid carrier
Inventor: HERSLOF BENGT
IPC: A61K47/14
Filed: 1999-12-03
Abstract: A pharmaceutical composition comprising a cyclosporin as an active substance in a lipid carrier, which carrier comprises membrane lipids in combination with monoglycerides and optionally non-polar lipids, which composition is characterized in being liquid at room temperature and containing 0.5-25 % cyclosporin, 10-45 % membrane lipids, 10-55 % monoglycerides and 0-45 % non-polar lipids. The composition is bioequivalent to a commercial drug containing in addition to cyclosporin and additives also toxic emulsifiers and ethanol.
Patent NZ-515962-A (NZ)
Title: Suspended bracket for tubing
Inventor: STAIGER RAYMOND DAVID
IPC: F16L3/00
Filed: 2001-12-06
Abstract: A bracket with a top portion for receiving suspension means, two gussets extending from the top portion to receive tightening means, at least one foot extending outwards from the distal end of each gusset in the direction of the top portion.
Patent NZ-525518-A (NZ)
Title: Liquid applicator with diametrically opposed wings
Inventor: TUFTS SCOTT A
IPC: A61M35/00
Filed: 2001-11-08
Abstract: A liquid applicator for applying a desired liquid to a surface includes an elongated closed ampule formed of a frangible material containing the desired liquid; a flexible elongated hollow body having axially opposed open and closed ends and presenting a central longitudinal axis, the body defining an internal chamber which is adapted to receive the ampule; and a porous element sealed to the body and closing off the open end thereof so that liquid flows through the element when the ampule is fractured. The body includes a pair of diametrically opposed wings projecting therefrom which form gripping members that are spaced from the body and supported for pivoting movement relative thereto.
Patent NZ-532504-A (NZ)
Title: Walking aid
Inventor: BRIDGE JOHN SAMUEL
IPC: A61H3/04
Filed: 2004-04-21
Abstract: A walking aid comprising a frame (11) comprising a pair of opposed side panels (15, 19), a forward panel (33) and a rear panel (13) which define a space dimensioned to accommodate an occupant in a standing position and a seated position, a seat (27) supported from the frame and positioned to support the occupant in the seated position, the seat being movable on the frame between an active position at which it is positioned to support the occupant in the seated position and an inactive position at which it lies substantially clear of the space, one panel being pivotally supported about an upright axis to be moveable from a closed position at which it is engaged with adjacent panels to an open position at which it is supported from only one panel and extends outwardly from the space to enable entry and exit by an occupant to and from the space, the frame being supported from the ground by a set of wheels (12), the side panels each having a hand support (23, 25) being positioned to be able to be engaged by the hands and/or arms of the occupant to enable the occupant to support themselves from the frame when in the standing position, and a braking means adapted to control the wheels, the braking means being connected to controls associated with the hand supports.
Patent NZ-535324-A (NZ)
Title: Building panel and construction method
Inventor: BLAZEVIC PAUL
IPC: E04B2/72
Filed: 2003-02-28
Abstract: Building panel (2), with spaced apart walls (4) forming cells (10) and with apertures (12). There is skin (14) that makes a projection (15) that allows the overlapping of one panel (2) with another panel (2).
Patent NZ-535429-A (NZ)
Title: Steering arrangement for a ship propelled by waterjet
Inventor: KARLSSON SVEN-GUNNAR
IPC: B63H11/11
Filed: 2003-04-30
Abstract: A steering arrangement for ships propelled by water jet, comprising a steering device (6) that is pivotal about an essentially vertical shaft (5) having a first centre line (C1), at least one hydraulic cylinder (2; 3) for turning the steering device, which hydraulic cylinder is directly or indirectly articulately connected to the ship's body at one of its ends (2B; 3B), a turning device (4) connected to the shaft, for attachment to a second end (2A; 3A) of the hydraulic cylinder at a distance from the shaft, a reversing device (7) arranged in connection with the steering device about an essentially horizontal shaft (12), an additional hydraulic cylinder (9) arranged to act on the reversing device, the additional hydraulic cylinder following the movement of the steering device, characterised in that all the hydraulic cylinders (2,3,9) are arranged within a sheltered space (1) located above the extension of the vertical shaft, which space is accessible for maintenance from the inside of the ship, and in that the arranging of the hydraulic cylinder at the turning device in relation to the steering device is arranged such that the relative position of the reversing device is uninfluenced by the relative position of the steering device.
Patent NZ-537952-A (NZ)
Title: Vanilloid receptor ligands and their use in treatments
Inventor: CHAKRABARTI PATHA P
IPC: C07D233/38
Filed: 2003-08-08
Abstract: Compounds having the general structure defined in the claims and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular and non-vascular syndromes, tension headache, general inflammation, arthritis, rheumatic diseases, osteoarthritis, inflammatory bowel disorders, inflammatory eye disorders, inflammatory or unstable bladder disorders, psoriasis, skin complaints with inflammatory components, chronic inflammatory conditions, inflammatory pain and associated hyperalgesia and allodynia, neuropathic pain and associated hyperalgesia and allodynia, diabetic neuropathy pain, causalgia, sympathetically maintained pain, deafferentation syndromes, asthma, epithelial tissue damage or dysfunction, herpes simplex, disturbances of visceral motility at respiratory, genitourinary, gastrointestinal or vascular regions, wounds, burns, allergic skin reactions, pruritus, vitiligo, general gastrointestinal disorders, gastric ulceration, duodenal ulcers, diarrhea, gastric lesions induced by necrotising agents, hair growth, vasomotor or allergic rhinitis, bronchial disorders or bladder disorders.
Patent NZ-539135-A (NZ)
Title: A transfer function system for determining an identifier on a surface acoustic wave identification tag
Inventor: HARTMANN CLINTON S
IPC: G08B13/24
Filed: 2003-09-30
Abstract: A system for determining an identifier on a surface acoustic wave (SAW) identification tag is disclosed. The system includes: (a) a means for generating a radio frequency (RF) interrogation signal that causes a transducer located on a piezoelectric substrate to produce an initial acoustic pulse that reflects off a plurality of reflectors arranged according to time and phase position on the substrate to yield response acoustic pulses, where the transducer generates an RF response signal from the response acoustic pulses, and (b) means for determining the identifier by decoding the RF response signal in view of predefined time, phase, and amplitude parameters.
Patent NZ-539623-A (NZ)
Title: Method for improving the durability, dimensional stability and surface hardness of a wooden body
Inventor: KRAUSE ANDREAS
Filed: 2003-10-01
Abstract: Disclosed is a process for the production of a wood body having high durability, dimensional stability and surface hardness, wherein an untreated wood body is impregnated with an aqueous solution of a) An impregnating agent from the group consisting of 1,3-bis(hydroxymethyl)-4,5-dihydroxyimidazolidin-2-one, 1,3-bis(hydroxymethyl)-4,5-dihydroxyimidazolidin-2-one modified with a C1-5 alcohol, a polyol or mixtures thereof, 1,3 dimethyl-4,5-dihydroxyimidazolidin-2-one, dimethylolurea, bis(methoxymethyl)urea, tetramethylolacetylenediurea, 1,3-bis(hydroxymethyl)imidazolidin-2-one, methylolmethylurea or mixture thereof; and b) A catalyst from the group consisting of the metal or ammonium salts, organic or inorganic acids or mixtures thereof. Then hardened while maintaining humid conditions at elevated temperature.
Patent NZ-540051-A (NZ)
Title: Selected CGRP antagonists, method for production and use thereof as medicament
Inventor: RUDOLF KLAUS
Filed: 2003-10-23
Abstract: Disclosed are CGRP antagonist compounds of formula (I), wherein the substituents are as defined in the specification. Also disclosed are processes for preparing the compounds.
Patent NZ-543148-A (NZ)
Title: Multiconfigurable device masking shunt and method of use
Inventor: REAMER DOUGLAS ALAN
IPC: H04L29/12
Filed: 2004-03-24
Abstract: A multiconfigurable device masking shunt for a network device, preferably on a secure network having a first mode and a second mode. In the first mode, the shunt cloaks the network device by rendering the network device invisible to upstream and downstream relay devices. During cloaking, the network device's media access control address is substituted with the upstream or downstream relay devices media access control address. In a second mode, the shunt passes inbound and outbound traffic through one of two alternate paths to the secure network from an insecure network and can monitor such traffic.
Patent NZ-544013-A (NZ)
Title: Sulfamate benzothiophene derivatives as steroid sulfatase inhibitors
Inventor: LAFAY JEAN
IPC: A61P35/00
Filed: 2003-05-16
Abstract: Disclosed is a compound of formula (Ia) or formula (Ib) wherein R1 is hydrogen, a (C1-6)alkyl, a (C2-6)alkene, a (C3-12)cycloalkyl or a (C3-12)cycloalkene wherein the cycloalkyl and the cycloalkene are optionally mono- or disubstituted with a (C1-4)alkyl; R2 is hydrogen; R'2 is a (C1-6)alkyl or a (C3-12)cycloalkyl; R3 is hydrogen, a (C1-6)alkoxy or a halogen; m is 0,1,2; n is 0,1,2; when m is 0, R1 and R2 can also form together a group -(CH2)p- in which p is 3, 4 or 5; and the dotted line indicates that the sulfamate group is in position 5- or 6- of the benzothiophene ring.
Patent NZ-551093-A (NZ)
Title: Concrete sideform system
Inventor: SLADOJEVIC ROBERT
IPC: E04G13/00
Filed: 2005-05-24
Abstract: This disclosure concerns a concrete side form system suitable for factory casting or site casting concrete. The side form comprises a substantially rigid longitudinally extending wall. The wall has a first face to define the edge profile of a concrete panel poured onto a casting bed bounded by the wall and a second face opposite the first face having formation to enable the wall to be secured to the casting bed. The wall comprises a longitudinally extending frame having formation along at least one of its edges to removably receive a removable longitudinal insert (13) to provide a shape along an edge of the concrete panel. The removable inserts (12, 13) provide the system with the ability to simply, easily and cost effectively change the edge profile of concrete poured against the side form; Architects can use the invention to specify standard or non standard edge profiles and achieve a much more diverse range of aesthetic finishes to the concrete edges without the cost being prohibitive.
Patent NZ-556681-A (NZ)
Title: Indolidone derivatives for the treatment or prevention of fibrotic diseases (vargatef, cryptogenic fibrosing alveolitis)
Inventor: PARK JOHN EDWARD
IPC: A61K31/404
Filed: 2005-12-21
Abstract: Disclosed is the use of the compound 3-Z-[1-(4-(N-((4-methylpiperazin-1-yl)-methylcarbonyl)-N-methyl-amino)-anilino)-1-phenyl-methylene]-6-methoxycarbonyl-2-indolinone (the pictured compound), or a tautomer, a diastereomer, an enantiomer, a mixture, or a salt thereof, for the prevention or treatment of idiopathic pulmonary fibrosis. Also disclosed is the use of other indolidone derivatives for the treatment of fibrotic diseases.
Patent NZ-563924-A (NZ)
Title: Riding apparatus and usage thereof
Inventor: SANDERS ERNEST DOUGLAS HANSEN
IPC: A63G31/00
Filed: 2007-11-29
Abstract: A ride on apparatus is disclosed. The apparatus includes a frame (2), and a steerable ground contact device (4) which is mounted from the frame and is pivotable about a steering axis. Two articulating assemblies (19) are mounted from the frame, both comprise a ground contact device (21) and a foot rest (20), and fit to the left and right hand sides of the frame. The ground contact device and footrest are able to be moved relative to the frame as a result of being articulated relative to the frame through at least one axis. Forward stops (27) restrict the left and right hand articulating assemblies from pivoting past a forward position. Biasing arrangements (30) bias the left and right articulating arrangements to a forwards position.
Patent NZ-565239-A (NZ)
Title: Measuring switch power using detected current and voltage read from a data sheet in a memory
Inventor: WOBBEN ALOYS
IPC: G01R21/133
Filed: 2006-07-28
Abstract: Disclosed is a method of determining the dissipated power of an electronic switch having a free-wheeling diode associated with the electronic switch. The method comprising the steps of: measuring the instantaneous value of a current through the switch; reading out a collector-emitter-voltage associated with the current based on data off a data sheet of the switch stored in a memory; multiplying the current value by the voltage value to determine the instantaneous dissipated power of the switch; and outputting the ascertained dissipated power. Determining the dissipated power includes switching losses and flow losses associated with operation of the switch.
Patent NZ-567653-A (NZ)
Title: Carbamate compounds as 5-HT4 receptor agonists
Inventor: LONG DANIEL
IPC: A61K31/46
Filed: 2006-11-21
Abstract: Benzoimidazolone-carboxamide-derived carbamate 5-HT4 receptor agonist compounds of formula (I) are disclosed, wherein R1, R2, R3, R4, a, and b are as defined in the specification. The disclosure also relates to pharmaceutical compositions comprising such compounds, methods of using such compounds to treat diseases associated with 5 HT4 receptor activity, and processes and intermediates useful for preparing such compounds.
Patent NZ-568335-A (NZ)
Title: Piperazine derivatives as antimalarial agents
Inventor: BINKERT CHRISTOPH
IPC: C07D209/16
Filed: 2006-10-20
Abstract: Disclosed is a piperazine acrylamide of formula (I) wherein the variables are as disclosed in the description. Also disclosed is the use of a compound of formula (I) for the preparation of a medicament for the treatment and prevention of protozoal infections such as malaria. Further disclosed is a pharmaceutical composition comprising a compound of formula (I).
Patent NZ-569502-A (NZ)
Title: Improved targeted nucleotide exchange with LNA modified oligonucleotides
Inventor: BUNDOCK PAUL
IPC: C12N15/10
Filed: 2006-12-21
Abstract: Disclosed is a method for targeted alteration of a duplex acceptor DNA sequence, comprising combining the duplex acceptor DNA sequence with a donor oligonucleotide, wherein the duplex acceptor DNA sequence contains a first DNA sequence and a second DNA sequence which is the complement of the first DNA sequence and wherein the donor oligonucleotide comprises a domain that comprises at least one mismatch with respect to the duplex acceptor DNA sequence to be altered, and wherein the oligonucleotide comprises a section that contains at least two modified nucleotides having a higher binding affinity compared to naturally occurring A, C, T or G and wherein the modified nucleotides bind stronger to a nucleotide in an opposite position in the first DNA sequence as compared to a naturally occurring nucleotide complementary to the nucleotide in an opposite position in the first DNA sequence, in the presence of proteins that are capable of targeted nucleotide exchange, wherein the at least two modified nucleotides are LNAs, wherein the LNAs are distributed independently over a distance of at most 6 nucleotides from both sides of the mismatch, and wherein said method is not performed in vivo in a human. Also claimed are the oligonucleotides and the use of the oligonucleotides in the manufacture of a medicament.